Search
Now showing items 1-1 of 1
Protocol - modelling predictors for relapsing disease in MOGAD
(The University of Nottingham, 2023-01-16)
In myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD), only approximately 40%-60% of patients develop a relapsing disease course, for which the preventative treatment is long-term immunotherapy. Due ...